TEMSIROLIMUS ACCORD 30mg concentrate + solvent infusion solution - medication leaflet

L01EG01 temsirolimus

Medicine TEMSIROLIMUS ACCORD 30mg contains substance temsirolimus , ATC code L01EG01 - Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mammalian target of rapamycin (MTOR) kinase inhibitors .

General data about TEMSIROLIMUS ACCORD 30mg ACCORD

Substance: temsirolimus

Date of last drug list: 01-09-2021

Commercial code: W67928001

Concentration: 30mg

Pharmaceutical form: concentrate + solvent infusion solution

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACCORD HEALTHCARE POLSKA SP. Z. O.O. - POLONIA

Holder: ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA

Number: 13948/2021/01

Shelf life: 3 years-after packing for marketing;dupa diluare-it is used immediately

Concentrations available for temsirolimus

25mg/ml, 30mg

Other medicine substances of the same pharmaceutical group with temsirolimus